{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:26:28Z","timestamp":1791588388309,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5638,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1538-7836.2007.02588.x","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T18:25:32Z","timestamp":1182277532000},"page":"1420-1430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["von Willebrand factor\/factor VIII concentrate (Haemate\u00ae P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery"],"prefix":"10.1016","volume":"5","author":[{"given":"S.","family":"LETHAGEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"KYRLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"CASTAMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"HAERTEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"MANNUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2516.2001.00498.x","article-title":"Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America","volume":"7","author":"Cohen","year":"2001","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02588.x_bb0020","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.mbc.0000167658.85143.49","article-title":"Management of von Willebrand disease with factor VIII\/von Willebrand factor concentrates: results from current studies and surveys","volume":"16","author":"Federici","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.1998.0040s3001.x","article-title":"Summary of a workshop on potency and dosage of von Willebrand factor concentrates","volume":"4","author":"Chang","year":"1998","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand\u2019s disease with a VHP vWF concentrate: the French experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02588.x_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2516.2001.00096.x","article-title":"Use of ristocetin cofactor activity in the management of von Willebrand disease","volume":"7","author":"Ewenstein","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high\u2010purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02588.x_bb0045","doi-asserted-by":"crossref","first-page":"P1673","DOI":"10.1111\/j.1538-7836.2003.tb05768.x","article-title":"Determination of high\u2010molecular weight von Willebrand factor multimers and their impact on specific VWF\u2010activities in VWF\/FVIII concentrates","author":"Walter","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V63.1.128.128","article-title":"Adhesion of platelets to human artery subendothelium: effect of factor VIII\u2010von Willebrand factor of various multimeric composition","volume":"63","author":"Sixma","year":"1984","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1989.tb00226.x","article-title":"Binding of von Willebrand factor to glycoproteins Ib and IIb\/IIIa complex: affinity is related to multimeric size","volume":"73","author":"Federici","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"Von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann Hematol"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2516.1998.0040s3025.x","article-title":"Characterization of factor VIII\/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis","volume":"4","author":"Metzner","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2516.2004.00893.x","article-title":"A comparative in vitro evaluation of six von Willebrand factor concentrates","volume":"10","author":"Lethagen","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM198704093161505","article-title":"Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions","volume":"316","author":"Schimpf","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0080","first-page":"304","article-title":"Haemate P in children with von Willebrand\u2019s disease","volume":"24","author":"Kreuz","year":"1994","journal-title":"Haemostasis"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate\u2010P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1612977","article-title":"Efficacy and safety of the factor VIII\/von Willebrand factor concentrate, Haemate\u2010P\/Humate\u2010P: ristocetin cofactor unit dosing in patients with von Willebrand disease","volume":"87","author":"Lillicrap","year":"2002","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02588.x_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2002-30198","article-title":"Sixteen years of treatment with pasteurized human clotting factor concentrates in children and adolescents: a pharmacosurveillance investigation comprising 727 patient years","volume":"28","author":"Muntean","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1351-8216.2003.00809.x","article-title":"Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII\/VWF concentrate (Humate\u2010P)","volume":"10","author":"Thompson","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0022215100130373","article-title":"Bleeding after tonsillectomy in severe von Willebrand\u2019s disease","volume":"109","author":"Alusi","year":"1995","journal-title":"J Laryngol Otol"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2007.02588.x_bb0110","first-page":"514","article-title":"Successful cardiac surgery in a young girl with type 2a von Willebrand disease using continuous infusion of Haemate\u2010P","volume":"77","author":"Naqvi","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2007.02588.x_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2516.1999.0050s2064.x","article-title":"Haemostatic treatment in connection with surgery in patients with von Willebrand disease","volume":"5","author":"Lethagen","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0037-1614448","article-title":"Safety and efficacy of continuous infusion of a combined factor VIII\u2010von Willebrand factor (vWF) concentrate (Haemate\u2010P) in patients with von Willebrand disease","volume":"81","author":"Lubetsky","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ajh.1058","article-title":"Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease","volume":"66","author":"Nitu\u2010Whalley","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0130","first-page":"1279","article-title":"Efficacy and safety of factor VIII\/von Willebrand\u2019s factor concentrate (Haemate\u2010P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease","volume":"88","author":"Franchini","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00001721-200406000-00006","article-title":"Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII\u2010von Willebrand factor concentrate (Haemate\u2010P)","volume":"15","author":"Michiels","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Budde","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0145","first-page":"160","article-title":"The standardization of certain factors in the cutaneous \u2018venostasis\u2019 bleeding time technique","volume":"84","author":"Ivy","year":"1941","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random\u2010effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2307\/3314658","article-title":"Refining binomial confidence intervals","volume":"14","author":"Casella","year":"1986","journal-title":"Can J Stat"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2516.1998.0040s3015.x","article-title":"The determination of von Willebrand factor activity by collagen binding assay","volume":"4","author":"Siekmann","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate\u2010P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy","volume":"9","author":"Gill","year":"2003","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2007.02588.x_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2516.1998.0040s3044.x","article-title":"Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2","volume":"4","author":"Menache","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","article-title":"Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep\u2010vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2004.01033.x","article-title":"Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis","volume":"3","author":"Bank","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0037-1614553","article-title":"Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions","volume":"81","author":"Kamphuisen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1613748","article-title":"Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response","volume":"83","author":"O\u2019Donnell","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.blo.0000128971.35014.31","article-title":"Risk factors for pulmonary emboli after total hip or knee arthroplasty","author":"Mont","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1160\/TH04-04-0251","article-title":"The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism","volume":"93","author":"Tirado","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0225","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1160\/TH05-01-0013","article-title":"Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada \u2013 is it necessary to define a new upper reference range for factor VIII?","volume":"93","author":"Wells","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0230","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.2004.00886.x","article-title":"Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors\u2019 Organization","volume":"10","author":"Pasi","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02588.x_bb0240","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand\u2019s Disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622104617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622104617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02588.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:43:12Z","timestamp":1761532992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622104617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1538783622104617"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02588.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand factor\/factor VIII concentrate (Haemate\u00ae P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02588.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}